预测心力衰竭存活率的机器学习:对当前模型和未来前景的审查
Emmanuel Kokori1, Ravi Patel2, Gbolahan Olatunji1
1Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
Heart failure reviews
|December 10, 2024
概括
与传统方法相比,机器学习算法显著改善了心力衰竭生存预测. 这些先进的模型识别了关键的风险因素,提高了患者风险分层和个性化治疗策略.
科学领域:
- 心脏病学 心脏病学
- 人工智能在医学中的应用
- 生物统计学 生物统计学
背景情况:
- 心力衰竭 (HF) 是一种广泛的疾病,影响患者的治疗和生存预后.
- 传统的HF生存预测模型往往由于固定的预测因素和独立性假设而缺乏准确性.
- 机器学习 (ML) 通过分析复杂的数据模式,提供了更准确的HF生存预测的潜力.
研究的目的:
- 评估ML算法在预测心力衰竭存活率方面的有效性.
- 将ML性能与传统的统计方法进行比较.
- 为了确定心力衰竭生存的关键预测特征.
主要方法:
- 对使用ML进行心力衰竭生存预测的研究进行了系统审查.
- 文献搜索包括主要的数据库 (PubMed,谷歌学者等). 在2024年7月之前.
- 分析重点是10项涉及468,171名心力衰竭患者的研究.
主要成果:
- 机器学习算法,特别是随机森林和梯度增强,超过了传统模型.
- 极端学习机器 (ELM) 和CatBoost显示出高的预测准确性 (C指数,AUC).
- 确定的主要预测因素包括射出分数 (EF),血清肌素 (S Cr) 和血液尿素 (BUN).
结论:
- ML算法提供了对心力衰竭存活率和风险分层的优越预测.
- 整合ML可以个性化治疗并改善患者的治疗结果.
- 解决数据质量,可解释性和临床工作流集成对于ML采用至关重要.
更多相关视频
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:24Kaplan-Meier Approach
98
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
98
01:20Comparing the Survival Analysis of Two or More Groups
150
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
150
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316